Top Markets
Coin of the day
Xcell Therapeutics, Inc. Xcell Therapeutics, Inc.

Xcell Therapeutics, Inc.

373110
Classifica tra le azioni #30829
Xcell Therapeutics Inc. engages in the development and production of drugs for... Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells. In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.
Prezzo delle azioni
$0.88649477
Capitalizzazione di mercato
$15.33M
Variazione (1 giorno)
-3.61%
Variazione (1 anno)
-54.45%
Paese
KR
Scambia Xcell Therapeutics, Inc. (373110)

Categoria

Storico del rendimento da dividendi per Xcell Therapeutics, Inc. (373110)
Il rendimento da dividendi (TTM) di Xcell Therapeutics, Inc. (simbolo azionario: 373110) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Xcell Therapeutics, Inc. (373110) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.48%
BE